Claudin-1 (CLDN1) as a new therapeutic target in colorectal cancer: Inhibition of cell growth and survival by an anti-CLDN1 monoclonal antibody

被引：1
|
作者：
Ayrolles-Torro, Adeline [1 ,2 ,3 ]
Vezzio-Vie, Nadia [1 ,2 ,3 ]
Denis, Vincent [1 ,2 ,3 ]
Boissiere-Michot, Florence [4 ]
Garambois, Veronique [1 ,2 ,3 ]
Busson, Muriel [1 ,2 ,3 ]
Arsa, Imade Ait [1 ,2 ,3 ]
Mollevi, Caroline [4 ]
Pugniere, Martine [1 ,2 ,3 ]
Bibeau, Frederic [4 ]
Martineau, Pierre [1 ,2 ,3 ]
Gongora, Celine [1 ,2 ,3 ]
Del Rio, Maguy [1 ,2 ,3 ]
机构：
[1] IRCM, Montpellier, France
[2] INSERM, U896, Montpellier, France
[3] Univ Montpellier I, Montpellier, France
[4] Inst Reg Canc Montpellier, ICM, Montpellier, France
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B245
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer.
    Bai, Chunmei
    Xue, Junli
    Zheng, Yi
    Sun, Meili
    Ying, Jieer
    Zhou, Fuxiang
    Yu, Yiyi
    Sun, Yuping
    Xing, Ligang
    Zhang, Yanqiao
    Wen, Jinhua
    Xiong, Jianping
    Wu, Heshui
    Yang, Xiuli
    Wan, Lixin
    Guo, Shiwei
    Zhao, Rusen
    Zhu, Zhizhen
    Gong, Zhihua
    Li, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma
    Upadhaya, Puja
    Barhoi, Dharmeswar
    Giri, Anirudha
    Bhattacharjee, Abhinandan
    Giri, Sarbani
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (10) : 18117 - 18127
  • [43] The Wnt-target Prox1 promotes colorectal cancer stem cell survival to fuel tumor growth
    Wiener, Zoltan
    Hyvonen, Ville
    Hogstrom, Jenny
    Holopainen, Tanja
    Band, Arja
    Kallio, Pauliina
    Dufva, Olli
    Haglund, Caj
    Kruuna, Olli
    Oliver, Guillermo
    Ben-Neriah, Yinon
    Alitalo, Kari
    CANCER RESEARCH, 2014, 74 (19)
  • [44] A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody
    Curtin, Francois
    Bernard, Corinne
    Levet, Sandrine
    Perron, Herve
    Porchet, Herve
    Medina, Julie
    Malpass, Sam
    Lloyd, David
    Simpson, Richard
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2075 - 2084
  • [45] The MACC1-SPON2 axis: a new biomarker and therapeutic target in colorectal cancer
    Chandrasinghe, P.
    Stebbing, J.
    Warusavitarne, J.
    ONCOGENE, 2017, 36 (11) : 1474 - 1475
  • [46] The MACC1-SPON2 axis: a new biomarker and therapeutic target in colorectal cancer
    P Chandrasinghe
    J Stebbing
    J Warusavitarne
    Oncogene, 2017, 36 : 1474 - 1475
  • [47] Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt
    Yeh, Juddi
    Litz, Julie
    Hauck, Paula
    Ludwig, Dale L.
    Krystal, Geoffrey W.
    LUNG CANCER, 2008, 60 (02) : 166 - 174
  • [48] Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer
    Huang, Fang
    Zhao, Yingchao
    Zhao, Junzhang
    Wu, Shuang
    Jiang, Yao
    Ma, Hong
    Zhang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 6006 - 6014
  • [49] Anti-PAI-1 Monoclonal Antibody Inhibits the Metastasis and Growth of Esophageal Squamous Cell Carcinoma
    Zheng, Yutian
    Meng, Lin
    Qu, Like
    Zhao, Chuanke
    Wang, Lixin
    Liu, Caiyun
    Shou, Chengchao
    JOURNAL OF CANCER, 2023, 14 (01): : 114 - 128
  • [50] Diagnostic and therapeutic evaluation of an anti-Langerhans cell histiocytosis monoclonal antibody (NA1/34) in a new xenograft model
    Murray, S
    Rowlinson-Busza, G
    Morris, JF
    Chu, AC
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 127 - 134
12345